Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and Apoplexy

omega-n-methylarginine has been researched along with Apoplexy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E1
Ally, A; Maher, TJ; Phattanarudee, S; Towiwat, P1
Cleland, SJ; Dawson, J; Harrow, C; Lees, KR; Quinn, T; Walters, MR; Weir, CJ1
Alem, M; Cleland, SJ; Connell, JM; Lees, KR; Nazir, FS; Small, M; Walters, MR1
Balla, C; Cosentino, F; De Luca, N; De Sensi, F; De Siati, L; Francia, P; Musumeci, B; Rao, MA; Volpe, M1

Trials

1 trial(s) available for omega-n-methylarginine and Apoplexy

ArticleYear
Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
    Diabetes care, 2009, Volume: 32, Issue:1

    Topics: Allopurinol; Carotid Arteries; Cerebrovascular Circulation; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Humans; Infusions, Intravenous; Male; Nitric Oxide; omega-N-Methylarginine; Placebos; Stroke

2009

Other Studies

4 other study(ies) available for omega-n-methylarginine and Apoplexy

ArticleYear
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
    The Journal of clinical endocrinology and metabolism, 2017, 06-01, Volume: 102, Issue:6

    Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry

2017
Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke.
    Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:7

    Topics: Animals; Arginine; Cardiovascular System; Female; gamma-Aminobutyric Acid; Glutamic Acid; Infarction, Middle Cerebral Artery; Microdialysis; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; omega-N-Methylarginine; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reperfusion; Stroke; Synaptic Transmission

2013
Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:4

    Topics: Adult; Area Under Curve; Carotid Arteries; Case-Control Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Regional Blood Flow; Risk; Stroke; Ultrasonography, Doppler, Transcranial

2006
Nitric oxide release is impaired in hypertensive individuals with familial history of stroke.
    American journal of hypertension, 2006, Volume: 19, Issue:12

    Topics: Adult; Blood Flow Velocity; Endothelium, Vascular; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Humans; Hyperemia; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Pedigree; Phenotype; Radial Artery; Stroke; Ultrasonography; Vasodilation; Vasodilator Agents

2006